A pilot open-label feasibility trial examining an adjunctive mindfulness intervention for adolescents with obesity
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2055-5784
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
A pilot open-label feasibility trial examining an adjunctive mindfulness intervention for adolescents with obesity ; volume:6 ; number:1 ; day:6 ; month:6 ; year:2020 ; pages:1-11 ; date:12.2020
Pilot and feasibility studies ; 6, Heft 1 (6.6.2020), 1-11, 12.2020
- Urheber
-
Cotter, Elizabeth W.
Hornack, Sarah E.
Fotang, Jenny P.
Pettit, Elizabeth
Mirza, Nazrat M.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40814-020-00621-1
- URN
-
urn:nbn:de:101:1-2020080719074605585853
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:45 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Cotter, Elizabeth W.
- Hornack, Sarah E.
- Fotang, Jenny P.
- Pettit, Elizabeth
- Mirza, Nazrat M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Safety and Tolerability of Adjunctive Brivaracetam in Pediatric Patients < 16 Years with Epilepsy: An Open-Label Trial
Long-term efficacy and safety from an open-label extension of adjunctive cenobamate in patients with uncontrolled focal seizures
Long‐term safety and efficacy of adjunctive brivaracetam in pediatric patients with epilepsy: an open‐label, follow‐up trial
Results from a long-term open-label extension study of adjunctive buprenorphine/samidorphan combination in patients with major depressive disorder
Adjunctive tonic motor activation enables opioid reduction for refractory restless legs syndrome: a prospective, open-label, single-arm clinical trial
A Semi-Naturalistic, Open-Label Trial Examining the Effect of Prescribed Medical Cannabis on Neurocognitive Performance
Bacillus clausii as adjunctive treatment for acute community-acquired diarrhea among Filipino children: a large-scale, multicenter, open-label study (CODDLE)
Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin–norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study
Adjunctive use of mindfulness-based mobile application in depression: randomized controlled study
Examining How Headspace Impacts Mindfulness Mechanisms Over an 8-Week App-Based Mindfulness Intervention
Perampanel as monotherapy or first adjunctive therapy in pediatric and adult patients with epilepsy: the first United States-based phase IV open-label ELEVATE study
A single-arm, open-label pilot study of neuroimaging, behavioral, and peripheral inflammatory correlates of mindfulness-based stress reduction in multiple sclerosis
Safety and Tolerability of Adjunctive Brivaracetam in Pediatric Patients < 16 Years with Epilepsy: An Open-Label Trial
Long-term efficacy and safety from an open-label extension of adjunctive cenobamate in patients with uncontrolled focal seizures
Long‐term safety and efficacy of adjunctive brivaracetam in pediatric patients with epilepsy: an open‐label, follow‐up trial
Results from a long-term open-label extension study of adjunctive buprenorphine/samidorphan combination in patients with major depressive disorder
Adjunctive tonic motor activation enables opioid reduction for refractory restless legs syndrome: a prospective, open-label, single-arm clinical trial
A Semi-Naturalistic, Open-Label Trial Examining the Effect of Prescribed Medical Cannabis on Neurocognitive Performance
Bacillus clausii as adjunctive treatment for acute community-acquired diarrhea among Filipino children: a large-scale, multicenter, open-label study (CODDLE)
Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin–norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study
Adjunctive use of mindfulness-based mobile application in depression: randomized controlled study
Examining How Headspace Impacts Mindfulness Mechanisms Over an 8-Week App-Based Mindfulness Intervention
Perampanel as monotherapy or first adjunctive therapy in pediatric and adult patients with epilepsy: the first United States-based phase IV open-label ELEVATE study
A single-arm, open-label pilot study of neuroimaging, behavioral, and peripheral inflammatory correlates of mindfulness-based stress reduction in multiple sclerosis
Safety and Tolerability of Adjunctive Brivaracetam in Pediatric Patients < 16 Years with Epilepsy: An Open-Label Trial
Long-term efficacy and safety from an open-label extension of adjunctive cenobamate in patients with uncontrolled focal seizures
Long‐term safety and efficacy of adjunctive brivaracetam in pediatric patients with epilepsy: an open‐label, follow‐up trial
Results from a long-term open-label extension study of adjunctive buprenorphine/samidorphan combination in patients with major depressive disorder
Adjunctive tonic motor activation enables opioid reduction for refractory restless legs syndrome: a prospective, open-label, single-arm clinical trial
A Semi-Naturalistic, Open-Label Trial Examining the Effect of Prescribed Medical Cannabis on Neurocognitive Performance
Bacillus clausii as adjunctive treatment for acute community-acquired diarrhea among Filipino children: a large-scale, multicenter, open-label study (CODDLE)
Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin–norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study
Adjunctive use of mindfulness-based mobile application in depression: randomized controlled study
Examining How Headspace Impacts Mindfulness Mechanisms Over an 8-Week App-Based Mindfulness Intervention
Perampanel as monotherapy or first adjunctive therapy in pediatric and adult patients with epilepsy: the first United States-based phase IV open-label ELEVATE study